Inventor · disambiguated record
Adisa Kuburas
Also filed as: KUBURAS ADISA
9 granted patents·1 pending application·59 citations·filing 2012–2021
87Inventor score
Top patents by PatentIndex Score
10 records- 0195US11993648B2Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversionH LUNDBECK AS·Filed 2020·Granted May 28, 2024·3 cites·9 claims
- 0295US10266587B2Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferersALDERBIO HOLDINGS LLC·Filed 2017·Granted Apr 23, 2019·12 cites·4 claims
- 0391US10981984B2Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversionALDER BIOPHARMACEUTICALS INC·Filed 2018·Granted Apr 20, 2021·3 cites·9 claims
- 0491US10844116B2Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobiaALDERBIO HOLDINGS LLC·Filed 2016·Granted Nov 24, 2020·3 cites·9 claims
- 0590US9855332B2Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levelsRUSSO ANDREW F·Filed 2012·Granted Jan 2, 2018·18 cites·30 claims
- 0690US9708393B2Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferersRUSSO ANDREW F·Filed 2012·Granted Jul 18, 2017·19 cites·42 claims
- 0780US11325967B2Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferersH LUNDBECK AS·Filed 2019·Granted May 10, 2022·1 cites·10 claims
- 0876US2021380676A1Methods of determining whether anti-pacap antibodies inhibit pacap-associated photophobia or light aversionH LUNDBECK AS·Filed 2021·Application pending·0 cites
- 0971US11027018B2Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levelsALDERBIO HOLDINGS LLC·Filed 2019·Granted Jun 8, 2021·0 cites·18 claims
- 1067US10765746B2Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levelsALDERBIO HOLDINGS LLC·Filed 2017·Granted Sep 8, 2020·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Adisa Kuburas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →